Cargando…
The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity?
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder with an unknown etiology and no effective treatment, and is characterized by large phenotypic heterogeneity, including variable sites, ages of symptom onset and rates of disease progression. Increasing data support the role of the m...
Autores principales: | Niccolai, Elena, Di Pilato, Vincenzo, Nannini, Giulia, Baldi, Simone, Russo, Edda, Zucchi, Elisabetta, Martinelli, Ilaria, Menicatti, Marta, Bartolucci, Gianluca, Mandrioli, Jessica, Amedei, Amedeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301418/ https://www.ncbi.nlm.nih.gov/pubmed/34209688 http://dx.doi.org/10.3390/biomedicines9070753 |
Ejemplares similares
-
Characterization of the “gut microbiota-immunity axis” and microbial lipid metabolites in atrophic and potential celiac disease
por: Ricci, Federica, et al.
Publicado: (2022) -
Corrigendum: Characterization of the “gut microbiota-immunity axis” and microbial lipid metabolites in atrophic and potential celiac disease
por: Ricci, Federica, et al.
Publicado: (2023) -
Evaluation and comparison of short chain fatty acids composition in gut diseases
por: Niccolai, Elena, et al.
Publicado: (2019) -
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis’ Strains Isolated from Healthy Donors and Colorectal Cancer Patients
por: De Almeida, Carolina Vieira, et al.
Publicado: (2019) -
Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy
por: Russo, Edda, et al.
Publicado: (2022)